Tanasi™ Introduces Innovative 1:1 CBD+CBDA Formula
Recently, GreenWay Tanasi, LLC, the wellness company behind Tanasi™, revealed an exciting new development about its product line. They have secured a U.S. patent for their unique 1:1 formulation of cannabidiol (CBD) and cannabidiolic acid (CBDA), marking a significant milestone for their offerings. This proprietary formula, which is exclusively licensed from GreenWay Herbal Products, LLC, showcases Tanasi's commitment to scientific integrity in the wellness sector.
What Makes the 1:1 Formula Unique?
The innovative 1:1 blend of CBD and CBDA has been crafted to harness the full potential of hemp-derived components. This balanced composition of cannabinoids is designed to preserve both their acidic and neutral forms, ensuring users receive holistic benefits. Scientific studies indicate that this combination has shown heightened biological activity compared to using CBD alone. With products ranging from gummies to tinctures and topical applications, Tanasi ensures diverse options for consumers while maintaining a consistent formulation strategy.
Supporting Daily Wellness Routines
Customers of Tanasi have come to rely on these products as a beneficial part of their daily routines. From aiding in relaxation to enhancing restorative rest, the Tanasi products are designed to offer comfort without any psychoactive effects. This mission stands firmly rooted in the company's philosophy of prioritizing science over fleeting market trends, ensuring that each product reflects careful formulation and research.
Consumer Trust and Engagement
With a growing customer base, Tanasi continues to receive positive feedback driven by customer satisfaction. The brand maintains an impressive reputation, bolstered by thousands of verified reviews underscoring trust and consistent repeat purchases.
About the Company
Founded in 2019, Tanasi specializes in creating hemp-derived dietary supplements and topicals. Their patented 1:1 CBD+CBDA formulation was developed through rigorous research and aims to meet consumer needs for calm and relief. All products are non-psychoactive and adhere to the highest standards to promote everyday use.
Tanasi's Commitment to Quality and Safety
While patents secure the intellectual property of their formulation, it is essential to note that these products have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not intended to diagnose, treat, or cure any ailments. Tanasi products serve as supplements designed to complement a balanced diet, fitting into the framework established by the Dietary Supplement Health and Education Act of 1994.
Frequently Asked Questions
What is the significance of the 1:1 CBD+CBDA formulation?
The 1:1 formulation is designed to optimize the effects of both cannabinoids, providing enhanced benefits compared to using CBD alone.
How do Tanasi products fit into a daily wellness routine?
Tanasi products can be seamlessly incorporated into everyday life to promote relaxation, rest, and general well-being.
Is Tanasi's formula patented?
Yes, the unique 1:1 CBD+CBDA formulation is protected by U.S. Patent No. 12,496,307, ensuring its innovation is secured.
Are Tanasi products psychoactive?
No, all Tanasi offerings are THC-free and non-psychoactive, allowing for use without intoxicating effects.
When were Tanasi products launched?
Tanasi products were launched in 2019, reflecting a commitment to quality and scientific research in their formulation.
